重度但无症状原发性二尖瓣反流主动监测的长期结局
本研究在心脏瓣膜门诊随访项目中前瞻性纳入280例重度无症状原发性二尖瓣反流患者,每6个月进行临床和超声心动图检查直至达到手术标准。中位潜在随访93.4个月期间,161例出现手术指征、13例死亡,总体生存率与年龄性别匹配的一般人群相当,早期生存率甚至更优(标准化死亡比0.667,95%CI 0.463–0.963,p=0.013)。
要点
- 重度无症状原发性二尖瓣反流患者可长期无手术指征,需每6个月临床和超声心动图随访。
- 主动监测下总体生存率与匹配人群相当,标准化死亡比0.667(95%CI 0.463–0.963,p=0.013)。
核心结论
- 重度无症状原发性二尖瓣反流患者可能长期无手术指征,在有经验的中心进行主动监测与良好预后相关,可实现及时转诊手术、极佳长期生存和良好手术结局。
研究设计与样本
- 前瞻性队列研究,1997年至2015年连续纳入280例重度无症状原发性二尖瓣反流患者,纳入心脏瓣膜门诊随访项目,每6个月进行临床和超声心动图检查直至达到手术标准。
诊断标准与关键数值
- 中位潜在随访93.4个月(四分位55.3至152.9个月),161例出现手术指征,13例死亡。
- 无事件生存率:2年78.0%(95%CI 73.2%–83.2%),6年52.2%(95%CI 46.3%–59.0%),10年35.5%(95%CI 29.3%–43.1%),15年18.7%(95%CI 12.3%–28.5%)。
- 总体生存率:2年99.6%(95%CI 98.9%–100%),6年94.6%(95%CI 91.7%–97.6%),10年85.6%(95%CI 80.3%–91.2%),15年74.5%(95%CI 66.6%–83.4%)。
- 标准化死亡比0.667(95%CI 0.463–0.963,p=0.013),早期生存率优于匹配人群。
临床应用与阅片要点
- 对重度无症状原发性二尖瓣反流患者,可在有经验的中心进行每6个月临床和超声心动图随访的主动监测,直至达到手术标准。
- 主动监测与及时转诊手术、极佳长期生存和良好手术结局相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: This study sought to assess the long-term outcome of active surveillance in these patients.
BACKGROUND: The optimal timing of mitral valve surgery in asymptomatic primary mitral regurgitation (MR) remains controversial.
METHODS: Between 1997 and 2015, 280 consecutive patients with severe asymptomatic primary MR were enrolled in our heart valve clinic follow-up program. They were prospectively followed up every 6 months clinical and echocardiographical examinations until surgical criteria were reached. Event-free survival and overall survival as compared with the age- and gender-matched general population were assessed.
RESULTS: During a median potential follow-up of 93.4 (quartiles 55.3 to 152.9) months, 161 patients developed an indication for surgery and 13 patients died. Event-free survival rates were 78.0% (95% confidence interval [CI]: 73.2% to 83.2%) at 2 years, 52.2% (95% CI: 46.3% to 59.0%) at 6 years, 35.5% (95% CI: 29.3% to 43.1%) at 10 years, and 18.7% (95% CI: 12.3% to 28.5%) at 15 years. Overall survival rate was 99.6% (95% CI: 98.9% to 100%) at 2 years, 94.6% (95% CI: 91.7% to 97.6%) at 6 years, 85.6% (95% CI: 80.3% to 91.2%) at 10 years, and 74.5% (95% CI: 66.6% to 83.4%) at 15 years. Overall survival of patients managed according to an active surveillance strategy was comparable with the expected cumulative survival and early survival rates were even better in the study population (standardized mortality ratio: 0.667; 95% CI: 0.463 to 0.963; p = 0.013).
CONCLUSIONS: Patients with severe asymptomatic primary MR may remain free of indications for surgery for extensive periods of time. In such patients, active surveillance performed in experienced centers is associated with a favorable prognosis, resulting in timely referral to surgery, excellent long-term survival, and good surgical outcomes.
引用
- Zilberszac R, Heinze G, Binder T, et al. Long-Term Outcome of Active Surveillance in Severe But Asymptomatic Primary Mitral Regurgitation. JACC Cardiovasc Imaging. 2018. PMID: 30031699. doi:10.1016/j.jcmg.2018.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。